Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.72 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.72 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.67 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.61 |
| ▸ | FAAH | O00519 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15649627 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL4741208 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL1059785 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL15649602 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL23833964 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL8006368 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL25183155 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL542910 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL11676490 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH | |
| SCHEMBL7325048 | 1.00 | PLA2G2A (0.72) | PLA2G2APLA2G5NOD1PLA2G10FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| CN-122094649-A | Personal care compositions | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4662197-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2025-12-17 | — | — | EP | disclosed |
| US-12257335-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2025054445-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-13 | — | — | WO | disclosed |
| US-20250073142-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2025-03-06 | — | — | US | disclosed |
| US-12083212-B2 | Personal care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2024-09-10 | — | — | US | disclosed |
| WO-2024165426-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-15 | — | — | WO | disclosed |
| CN-113710329-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20220023189-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2022-01-27 | — | — | US | disclosed |
| EP-1303260-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | Pericor Science, Inc. (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-1292618-A2 | VIP-RELATED PEPTIDES FOR THE TREATMENT OF SEXUAL DISORDERS IN WOMEN | RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) | 2003-03-19 | — | — | EP | disclosed |
| EP-1202706-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | Pericor Science, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001090144-A2 | VIP-RELATED PEPTIDES FOR THE TREATMENT OF SEXUAL DISORDERS IN WOMEN | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2001-11-29 | — | — | WO | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |
| US-4016287-A | COSMETIC AND ANTIINFLAMMATORY | BOEHRINGER INGELHEIM GMBH (DT) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250073142-A1 | Personal Care Compositions | CUTA, PROC, TTPA | PLA2G2A 1715/4885PLA2G5 553/4885NOD1 4822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.